Biotechnology AVX,ACR,AVP.......

[Joshuatree]

BLT up re 13% to 47c today .

[Lizard]

BLT up re 13% to 47c today .

BLT:ASX on a bit of a roll here and maybe a break-out day today.

There's a degree of excitement here as the Calimmune HIV trial must be beginning to see some results from the first cohort (4 only). This trial is in 3 cohorts of 4 patients each, with the first patient treated in July. I have to admire the patients that put themselves up for this - entering the programme will generally imply they've been off meds for 6 weeks, which carries a high degree of risk in itself.

While Calimmune is a licensee arrangement only, there is a lot of eyes on this work re potential for ddRNAI therapy. Additionally, the Benitec-owned therapy for Hep C should enter phaseI/IIa trials soon, so there is a double shot at proving the technology platform in the next 6-18 months.

My best spec hope for a 10-bagger at present - although I'm only just heading back to "break-even" at these levels, having bought my initial stake too early!

[Joshuatree]

Hi Lizard thanks for sharing again re BLT. I like "Best spec for a 10 bagger" im nearly a 1 bagger in little over a month; no skill involved with my timing mainly luck! very strong support atm@ 54.5c. cheers DJV

[Lizard]

Hi Lizard thanks for sharing again re BLT. I like "Best spec for a 10 bagger" im nearly a 1 bagger in little over a month; no skill involved with my timing mainly luck! very strong support atm@ 54.5c. cheers DJV

...and now 58.5cps... looks like it might be finally firing. Will go rev up the old Benitec thread somewhere.

[ozzie]

Roger Montgomery has given CGS a big write up:
http://rogermontgomery.com/new-inves...opportunities/




"CogState is capitalised at $34.7 million, has no debt, and
cash reserves and short term investments of $3.1 million in
the September quarter. The enterprise value, therefore,
is $31.6 million. Based on trailing sales of $12.6 million,
the enterprise value to sales ratio is 2.5 times ($31.6
million/$12.6 million).

To put that in perspective, Resmed and Cochlear usually
trade on an EV/sales multiple of 4-5 times; less-established
biotechs in the loss-making phase often trade around 3
times sales, and low-growth biotechs can have an EV/
sales of 0.5 to 1 times. High-growth biotechs trading on
an EV / sales multiple closer to 2 times sales are often
viewed as undervalued, on this simplistic metric.

CogState has plenty of upside potential
and arguably less risk than many emerging biotechs,
given it has a developed product, established revenue
base, and is on the cusp of faster commercialisation of its
newer products. "

[macduffy]

Comments on a few biotech stocks:

http://www.thebull.com.au/premium/a/...re-prices.html

[Lizard]

Sometimes even the most promising treatments might not be better than the old fashioned type:
http://www.theage.com.au/business/sprayon-skin-company-avita-medical-faces-investor-revolt-20131117-2xp49.html

"However, in its 2012 annual report the Armed Forces Institute of Regenerative Medicine said the trial had enrolled only 63 of 106 test subjects needed and was attracting ''just two to three'' new patients every month.
The AFIRM said that while the treatment appeared to work, three subjects had healed slowly after re-injuring their burn and ''the FDA is likely to inquire about the robustness of ReCell versus [standard bandages]''."

Interesting one. The email response from the company, posted on HC was interesting regarding the "re-injury" occurring as a result of application of silver compound - which affected the re-growing skin cells in the same way it would affect bacterial growth, I think? However, the admission seemed also an admission of sloppiness in procedure?

I took a good look at AVH today (think I once owned CCE for a short, break-even trade), and felt the technology was hugely promising, but the management delivery just doesn't seem to be quite there. Could be critical for a company that will likely need more cash. I passed, but think it is still worth watching.

[MrAT]

What about nanosonics, anyone done research into this company?
ASX code is NAN.

[Joshuatree]

flogged the rest of my NEU shares @12.5c and have applied for a greater figure @11.5c placement. Current s/p hitting 14c!!!!. Pretty crazy. Some very clever spruikers on H/C help the fervor. Have held for years.

[Joshuatree]

And back down to 12.7c lol